Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.64M Sell
16,022
-47
-0.3% -$16.8K 1.33% 21
2025
Q4
$5.26M Sell
16,069
-1,602
-9% -$508K 1.66% 14
2025
Q3
$4.99M Sell
17,671
-3,465
-16% -$1M 1.49% 14
2025
Q2
$5.92M Buy
21,136
+85
+0.4% +$24.1K 1.42% 11
2025
Q1
$6.58M Sell
21,051
-215
-1% -$63.5K 1.71% 6
2024
Q4
$5.54M Buy
21,266
+464
+2% +$138K 1.42% 9
2024
Q3
$6.7M Sell
20,802
-215
-1% -$70.3K 1.68% 6
2024
Q2
$6.57M Buy
21,017
+322
+2% +$94.6K 1.76% 6
2024
Q1
$5.88M Sell
20,695
-60
-0.3% -$17.6K 1.62% 7
2023
Q4
$5.98M Sell
20,755
-462
-2% -$126K 1.77% 6
2023
Q3
$5.7M Sell
21,217
-135
-0.6% -$33.7K 1.86% 8
2023
Q2
$4.74M Buy
21,352
+160
+0.8% +$37.1K 1.45% 11
2023
Q1
$5.12M Buy
21,192
+207
+1% +$50.8K 1.66% 9
2022
Q4
$5.51M Sell
20,985
-26
-0.1% -$6.97K 1.88% 9
2022
Q3
$4.74M Buy
21,011
+81
+0.4% +$19.6K 1.81% 7
2022
Q2
$5.09M Buy
20,930
+30
+0.1% +$7.35K 1.3% 15
2022
Q1
$5.05M Buy
20,900
+20,886
+149,186% +$4.8M 1.1% 18
2021
Q4
$3.15K Sell
14
-20,600
-100% -$4.35M ﹤0.01% 285
2021
Q3
$4.38M Buy
20,614
+377
+2% +$86.8K 1.03% 20
2021
Q2
$4.93M Sell
20,237
-35
-0.2% -$8.61K 1.17% 16
2021
Q1
$5.04M Buy
20,272
+702
+4% +$168K 1.3% 11
2020
Q4
$4.5M Buy
+19,570
New +$4.51M 1.27% 15

Other funds holding AMGN

McDonald Partners's AMGN Position: Q1 2026 in Review

McDonald Partners reduced its Amgen (AMGN) stake by 0.29% in Q1 2026, selling an estimated $16.8K and leaving 16,022 shares worth $5.64M. The position accounts for 1.33% of the portfolio, ranked #21.

McDonald Partners first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $6.7M in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • McDonald Partners held 16,022 shares of Amgen worth $5.64M as of Q1 2026.
  • McDonald Partners sold 47 Amgen shares in Q1 2026, an estimated $16.8K.
  • Amgen made up 1.33% of McDonald Partners's portfolio in Q1 2026, its #21 holding.
  • McDonald Partners first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • McDonald Partners's Amgen position peaked at $6.7M in Q3 2024.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on McDonald Partners's 13F filing for Q1 2026, filed 15 May 2026.